vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Metallus Inc. (MTUS). Click either name above to swap in a different company.
Metallus Inc. is the larger business by last-quarter revenue ($308.3M vs $268.1M, roughly 1.2× ACADIA PHARMACEUTICALS INC). Metallus Inc. runs the higher net margin — 1.8% vs 1.4%, a 0.4% gap on every dollar of revenue. On growth, Metallus Inc. posted the faster year-over-year revenue change (9.9% vs 9.7%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (5.3% CAGR vs 2.3%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
ACAD vs MTUS — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $268.1M | $308.3M |
| Net Profit | $3.6M | $5.4M |
| Gross Margin | — | 8.1% |
| Operating Margin | -1.7% | — |
| Net Margin | 1.4% | 1.8% |
| Revenue YoY | 9.7% | 9.9% |
| Net Profit YoY | — | 315.4% |
| EPS (diluted) | $0.02 | $0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $268.1M | $308.3M | ||
| Q4 25 | $284.0M | $267.3M | ||
| Q3 25 | $278.6M | $305.9M | ||
| Q2 25 | $264.6M | $304.6M | ||
| Q1 25 | $244.3M | $280.5M | ||
| Q4 24 | $259.6M | $240.5M | ||
| Q3 24 | $250.4M | $227.2M | ||
| Q2 24 | $242.0M | $294.7M |
| Q1 26 | $3.6M | $5.4M | ||
| Q4 25 | $273.6M | $-14.3M | ||
| Q3 25 | $71.8M | $8.1M | ||
| Q2 25 | $26.7M | $3.7M | ||
| Q1 25 | $19.0M | $1.3M | ||
| Q4 24 | $143.7M | $-21.4M | ||
| Q3 24 | $32.8M | $-5.9M | ||
| Q2 24 | $33.4M | $4.6M |
| Q1 26 | — | 8.1% | ||
| Q4 25 | 90.8% | 2.2% | ||
| Q3 25 | 92.2% | 11.4% | ||
| Q2 25 | 92.2% | 10.6% | ||
| Q1 25 | 91.7% | 7.8% | ||
| Q4 24 | 91.6% | 4.5% | ||
| Q3 24 | 92.5% | 5.3% | ||
| Q2 24 | 92.5% | 8.2% |
| Q1 26 | -1.7% | — | ||
| Q4 25 | 6.1% | -7.7% | ||
| Q3 25 | 12.8% | 3.6% | ||
| Q2 25 | 12.2% | 2.8% | ||
| Q1 25 | 7.9% | 1.0% | ||
| Q4 24 | 59.1% | -10.1% | ||
| Q3 24 | 12.6% | -3.1% | ||
| Q2 24 | 12.6% | 2.1% |
| Q1 26 | 1.4% | 1.8% | ||
| Q4 25 | 96.3% | -5.3% | ||
| Q3 25 | 25.8% | 2.6% | ||
| Q2 25 | 10.1% | 1.2% | ||
| Q1 25 | 7.8% | 0.5% | ||
| Q4 24 | 55.4% | -8.9% | ||
| Q3 24 | 13.1% | -2.6% | ||
| Q2 24 | 13.8% | 1.6% |
| Q1 26 | $0.02 | $0.13 | ||
| Q4 25 | $1.61 | $-0.34 | ||
| Q3 25 | $0.42 | $0.19 | ||
| Q2 25 | $0.16 | $0.09 | ||
| Q1 25 | $0.11 | $0.03 | ||
| Q4 24 | $0.86 | $-0.46 | ||
| Q3 24 | $0.20 | $-0.13 | ||
| Q2 24 | $0.20 | $0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $104.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $683.0M |
| Total Assets | $1.6B | $1.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $104.0M | ||
| Q4 25 | $177.7M | $156.7M | ||
| Q3 25 | $258.0M | $191.5M | ||
| Q2 25 | $253.6M | $190.8M | ||
| Q1 25 | $217.7M | $180.3M | ||
| Q4 24 | $319.6M | $240.7M | ||
| Q3 24 | $155.1M | $254.6M | ||
| Q2 24 | $177.1M | $272.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $0 | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $5.4M | ||
| Q4 24 | — | $5.4M | ||
| Q3 24 | — | $13.2M | ||
| Q2 24 | — | $13.2M |
| Q1 26 | — | $683.0M | ||
| Q4 25 | $1.2B | $686.0M | ||
| Q3 25 | $917.3M | $697.7M | ||
| Q2 25 | $822.4M | $690.0M | ||
| Q1 25 | $765.2M | $686.1M | ||
| Q4 24 | $732.8M | $690.5M | ||
| Q3 24 | $577.2M | $712.7M | ||
| Q2 24 | $516.7M | $736.3M |
| Q1 26 | $1.6B | $1.1B | ||
| Q4 25 | $1.6B | $1.1B | ||
| Q3 25 | $1.3B | $1.2B | ||
| Q2 25 | $1.2B | $1.1B | ||
| Q1 25 | $1.1B | $1.1B | ||
| Q4 24 | $1.2B | $1.1B | ||
| Q3 24 | $976.9M | $1.1B | ||
| Q2 24 | $914.1M | $1.1B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.01× | ||
| Q4 24 | — | 0.01× | ||
| Q3 24 | — | 0.02× | ||
| Q2 24 | — | 0.02× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
